Zachary Orsino
About Zachary Orsino
Zachary Orsino is a Scientist Investigator specializing in CAR-T at Bristol Myers Squibb in Summit, New Jersey. He has a background in microbiology, data analysis, and technical writing within the pharmaceutical industry.
Company
Zachary Orsino currently holds the position of Scientist Investigator - CAR-T at Bristol Myers Squibb. He is based in Summit, New Jersey, United States. His role involves working within the CAR-T cell therapy division, contributing to the development and implementation of innovative cancer treatments.
Previous Roles at Ferring Pharmaceuticals
Before joining Bristol Myers Squibb, Zachary Orsino worked at Ferring Pharmaceuticals as a QC Microbiology Technician. He held this role from 2019 to 2021. During this period, he was based in Parsippany, New Jersey. His responsibilities included conducting microbiological testing to ensure product safety and compliance with regulatory standards.
Previous Roles at Renaissance Pharmaceuticals
From 2017 to 2019, Zachary Orsino was employed at Renaissance Pharmaceuticals as a Gown Qualified Operator. In this role, he was involved in the aseptic manufacturing environment. His work supported pharmaceutical production processes, ensuring adherence to stringent contamination control protocols.
Education and Expertise
Zachary Orsino completed his Bachelor's degree in Biology/Biological Sciences, General from Rutgers University, where he studied from 2012 to 2016. He has developed expertise in a range of areas, including data analysis with a focus on trend reporting, and microbiological testing methods. Additionally, he is skilled in technical writing, Corrective and Preventative Action (CAPA) processes, and possesses a strong understanding of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).
Professional Skills
Zachary Orsino is proficient in various professional skills crucial to the pharmaceutical industry. His expertise includes technical writing, with a focus on clear and comprehensive documentation. He is also skilled in trend reporting and data analysis, which are essential for identifying patterns and ensuring quality control. Moreover, his knowledge extends to Corrective and Preventative Action (CAPA) processes and adherence to GMP and GLP standards.